MMA
AXSM icon

Miracle Mile Advisors’s Axsome Therapeutics AXSM Stock Holding History

Miracle Mile Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Sell
1,010
-500
-33% -$108K ﹤0.01% 880
2026
Q1 		$255K Buy
+1,510
New +$261K ﹤0.01% 779

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Miracle Mile Advisors's AXSM Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Axsome Therapeutics (AXSM) stake by 33% in Q2 2026, selling an estimated $108K and leaving 1,010 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Miracle Mile Advisors first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $255K in Q1 2026. 52 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Miracle Mile Advisors held 1,010 shares of Axsome Therapeutics worth $247K as of Q2 2026.
  • Miracle Mile Advisors sold 500 Axsome Therapeutics shares in Q2 2026, an estimated $108K.
  • Axsome Therapeutics made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #880 holding.
  • Miracle Mile Advisors first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Miracle Mile Advisors's Axsome Therapeutics position peaked at $255K in Q1 2026.
  • 52 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.